Poran, Marlyn A.
HRN: 26-05-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/17/2024
10/23/2024
IV
340 Mg
Q12H
Acute Gastritis W Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes